Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Near term impact on price
View:
Post by DJDawg on Oct 03, 2022 10:21am

Near term impact on price

Am I correct that the buyers of this new block of shares won't be able to sell for 4 months like the previous PP that was just announced. If so then it doesn't great new shares that will suddenly appear on the market. I guess it takes away some of the incentive for people to buy at current price as they can get some of these new shares plus a warrant.

Am I correct that people think it won't change too much and the price will hang out around the current level for a while till the next clinical trial announcement of some kind?

I like that it will give RDW enough cash that if he start some JV negotiation it won't be from an apparent position of desparation and low cash.

Thoughts?
Comment by Rumpl3StiltSkin on Oct 03, 2022 10:36am
I think this is already priced in. No one is selling. If you aren't already in on this deal then you have to buy at market. The market is priced higher than the PP... Very nice, IMO.
Comment by Infinity on Oct 03, 2022 10:43am
DJ,  I am so sure that we are negotiating from a position of weakness or out of desperation for cash flow.  I am not agains the current PP.  I wish the timing for the second PP had been phased out ove a 6 month time line.  Ideally,  after announcing the BTD application at a much higher price for both the shares and the warrants.  
Comment by Lesalpes29 on Oct 03, 2022 10:56am
Sometime it's difficult to believe that they want to get SP at the higher price possible.
Comment by Rumpl3StiltSkin on Oct 03, 2022 11:23am
Well heck, they need the money now to pay for GLP and the continuing Trial. Covid 19 chopped off about a years worth of finance $$, IMO. They did appear to keep this as small as possible. And the market could be back up in the .30s/.40s soon... :-) Not pushed by news even, just someone wanting a decent position...
Comment by Legit62 on Oct 03, 2022 12:12pm
Does anyone know why it was stated not to distribution to US news wires or dissemination in the United States????
Comment by Vikingstock on Oct 03, 2022 12:33pm
I believe the pp securities are not registered to be sold in the USA.
Comment by skys1 on Oct 03, 2022 12:50pm
Legit, check your messages
Comment by riverrrow on Oct 03, 2022 2:45pm
The time to do a financing is when there are buyers willing to invest.  Now is a very good time to lock in some more money.  GLTA.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250